{"name":"Vifor Pharma","slug":"vifor-pharma","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"PA21 with food and Losartan 2 hours later","genericName":"PA21 with food and Losartan 2 hours later","slug":"pa21-with-food-and-losartan-2-hours-later","indication":"Other","status":"phase_1"}]}],"pipeline":[{"name":"PA21 with food and Losartan 2 hours later","genericName":"PA21 with food and Losartan 2 hours later","slug":"pa21-with-food-and-losartan-2-hours-later","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMioAFBVV95cUxPd1ZXZTFyT2x6aWdtbzRaRFRaT1NkMVBXZ09KcXdieHhjX0dxTGNjRVpLSERLb09SNjRhYkxHa3lmZjV1Y05DcnF5YXN0a1lURGRwSGlXTC1OYVFhblN4bnNpczh3R093QzZEVVZYNkpsMF9RZzExV1lKUzFwaXM4TUVsLVZGVFdjOEdGU2FfT2k2dS0tY0s5UVpQc0JOZXk2?oc=5","date":"2026-02-12","type":"earnings","source":"Fierce Pharma","summary":"CSL's bleak earnings report helps explain why it made CEO switch - Fierce Pharma","headline":"CSL's bleak earnings report helps explain why it made CEO switch","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqAFBVV95cUxQYnktMG9PVGRPajF5Z3cxVFVxbEd4bkpGckNoWFdraVcxVUJoLUZLXzdockNKc0JKUGRDbENFT3hUZHpKR3oxZHZlcDQ4LUtzTmFFWnNjYnc3ell3TDhLLVNSNXMtTVQtY0xaSjdxcWJpVFZZZTYtQmVVWFE5YWNsbTN0aHgxYnhlZXVYbnNldllBVjVHU0VUdHVPdXZvNG1MbHJaXzNsTkM?oc=5","date":"2025-10-17","type":"pipeline","source":"Mishcon de Reya LLP","summary":"Abuse of dominance by disparagement: The CMA's investigation into Vifor Pharma - Mishcon de Reya LLP","headline":"Abuse of dominance by disparagement: The CMA's investigation into Vifor Pharma","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitwFBVV95cUxOZ2Rpbjk0REdaSzFQenE3OVNHekY5NTJOZWZ6T2pRbEFZLUZWMEZuZEdjckUtcGlpUzUyeS1rVDJtSEp3U3ZhWTZtWHNrYW9tN1Mwa3Z4eW9ReEE0YTRFVUZqX1FXNUx0NktmRERnTnpFRWVYNHZyaU5OQWpwQldhM2dwVG1kU3ZjSV92V3ZTdEV4clNuZGFvZVN0SG55UmJHR0dwWGRGRVNUSmhoSWRhWXQ4QWxTN3M?oc=5","date":"2025-10-08","type":"pipeline","source":"Fierce Pharma","summary":"Vifor to cut 55 jobs as parent company CSL pushes ahead with downsizing, savings drive - Fierce Pharma","headline":"Vifor to cut 55 jobs as parent company CSL pushes ahead with downsizing, savings drive","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinAFBVV95cUxPazdpQXFIcWkxVVVFRTJuZExkRHRmRWg0Vk15Z2tRZzdnNHg5LVc1RWs3Y1BBM3A0S2tEZ25RalFaQTdwMEtybTl6ZDlwOU9SdERjQmNLN1RnbWpHcXlIQmFmbXpEcjJOYjRpbjh0OFAzYjhXS2tDeGFlSE01c1E3ampheF9LSFNxazF4SkxXU3M3aFZiYzAyMUg1Sjg?oc=5","date":"2025-10-07","type":"pipeline","source":"PennLive.com","summary":"Pharmaceutical company to lay off 55 people in Pa. - PennLive.com","headline":"Pharmaceutical company to lay off 55 people in Pa.","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi_AFBVV95cUxQdWJBS1RhVW9mUU10VW5PUWEzbWVGYlJJQThJNGVuNG9BeFJUWTkyalItdjVJWEtiS01zRnlyMlNqWE9weVRFVEQ3NGxoWXI3ZkVtWFFERUNGMTBxRWpnTWNoV0xKS0xCX21JeDBWRDBuaHVIdFVTRGZlaWxjaFp6UlZhSGxvVWNtV2ZRX3hfNUVnbXAxeGhORWFBbkV0UkRneEJiY0RsREtHbFNuSEhsUnIxemJ0XzBhaWFxNk5wUWJHM1gteGNKRGR4VnpHWGFJYVlWdFZ3NDhEUXBySmVpZEs4OGlUTC1xQndWSkJKLVI0dUFkcFluNTZ2UEQ?oc=5","date":"2025-06-20","type":"pipeline","source":"Mayer Brown","summary":"Big Firms, Be Careful What You Say: First UK Competition Disparagement Decision Puts Large Companies On Notice - Mayer Brown","headline":"Big Firms, Be Careful What You Say: First UK Competition Disparagement Decision Puts Large Companies On Notice","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirgFBVV95cUxQcEhEdHFJd1poOGthQ2NyOTEwVm5vYURyODdvTEw4WTI0WF9fS052NVVQVE5ldHBNQXhmMjVFUXpLN2NxejBXZ1JTSklvSldFSkFQM0ZYZTFzNFA1VDFUMjAxQnpxYkp0TWdoY215LW51TGhfckh6RGprLXRpZ2pFVHBCZUdST2YySHF3X0RSMzgzcUZzNWhyRWt0LV9WbnctX1Y1ZlZvMlB0ZGxIb0E?oc=5","date":"2025-06-06","type":"pipeline","source":"Healthcare Today","summary":"Vifor Pharma agrees £23 million payment to settle anti-trust investigation - Healthcare Today","headline":"Vifor Pharma agrees £23 million payment to settle anti-trust investigation","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMifkFVX3lxTFB5bHcxTklJZzdVTDlOaThiUllCdVR4Z1ZfVjItZDVZMUZqY1RmSkdhbXFxSlhwRm56bXR6dUJGeHNkamlDUmJtYjZsN0NUODBVYkhnYXltQVRUOU1tZllqbU9IczdseTltZ2t5TXp2THlPaGoyMDRmMUpaRWY2dw?oc=5","date":"2024-12-11","type":"pipeline","source":"Yahoo Finance","summary":"Vifor Pharma offers £23m to NHS to resolve CMA investigation - Yahoo Finance","headline":"Vifor Pharma offers £23m to NHS to resolve CMA investigation","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwgFBVV95cUxPZ1lyM3UyZFhDYTNkeE1CNHhtU1JDZlFubnRFUkU2Tm9DVVlyN2E1ZzR2c2hVQlpJMm9xTTNtS3N0VzRIM0JVNTNOZ2FOcnBUUEotNXZNRW9JcjdnWFBVeENveDQ2SzAwN0NKOVJHeGVyRUdMQVg3ckg4RFE0d1JhYzZNMUpYRmNJeVA5WmJHeHRVTFVpcUl0ajZBU2RQX2NEcmtsbjg5OWFZZnhsaUpXcEV0NUVScHBRbDloS1RHMDRldw?oc=5","date":"2024-04-19","type":"pipeline","source":"Reuters","summary":"Vifor Pharma offers to fix alleged anti-competitive behaviour - Reuters","headline":"Vifor Pharma offers to fix alleged anti-competitive behaviour","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMid0FVX3lxTE1wYWlyaTJNNjB3UGxyRkxkMmtNUjAwS2NFMFR0UU5RejFxS0ViSzROQS1RWVV1d01aRDk2NFkydUNpZFhHQTJWaDJwVjNjUnFmdmc4aFd3aXBicFRvWjFaV2d3RjJmTHNVM3VaanZLNF9CZ0ZWSnA4?oc=5","date":"2023-06-01","type":"pipeline","source":"Global Biotechnology Company","summary":"Global Biotechnology Company - Global Biotechnology Company","headline":"Global Biotechnology Company","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi_AFBVV95cUxQRTJyZ2dibWp1SEJaMW80TzZVdlhtckYyY1RrbEhLSTVHX1NCa01TSlpBbXh3eXFvS1hSSXduVkI4aF9nWGJpbHFsdkdVV05QUFlkYjItOTEtTHE2UEJCR2x1Q1ptUXVmSkNTZnBZSjNTOFlzdTdGLVZmVVE1MUdjd0RhUWpuQ2VHYmJyNjZZOHV6SXdYNmNubVQ5M2tTdmhxV3lNY0pUVTdvUEN5Rm5fN0tRXy01MzdLeEZick5DdnRUMXNhczM4dzFVa0ZyeVBsSFRub2pzNElLSl9lV0hyeFpvWWhBSktLS2J2bktFd1otZTRMRjdKVU9HX0I?oc=5","date":"2022-03-08","type":"pipeline","source":"businesswire.com","summary":"Publication of definitive Interim Result for Vifor Pharma tender offer: CSL Behring AG declares offer successful - businesswire.com","headline":"Publication of definitive Interim Result for Vifor Pharma tender offer: CSL Behring AG declares offer successful","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirgFBVV95cUxPZTVPN3VRLTlSaFBaYjVkTVI5T1JJaWFuM0tFbFpKUkNqelhLbHZDUG82UGlTVS1VMUtjWlRRSXNSZVFCam8ycXlkODNGR1o4bXRRT01aMVBQMGRlajg4LVlfXzN6dHlEVzRLUTRDZVpQY2lYRWlac2hXTnZnUUdnTWwwMHZVaG5iODlYWVVCY0JnSjduTGJyOFlmYUNpSHlCOEZULVFOQ2VRNVpzN1E?oc=5","date":"2021-12-23","type":"deal","source":"Global Biotechnology Company","summary":"CSL to Acquire Vifor Pharma, a Leader in Kidney Care - Global Biotechnology Company","headline":"CSL to Acquire Vifor Pharma, a Leader in Kidney Care","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihgFBVV95cUxPZXQyZ0JkOG5mbF9zZUFib2wxa3dQR2hkR2Npc2lvRzk3NmhWb1BaUFVZWkFSaGJ6aGduM0k5RWZYR25nSWs0Z0xFT0F5UjRnNHZnLVh1dkR2bk4zeWZPaFRxZWJ2aUl5R3ZNSmJIaDY0elZHdjJneVJRMXk1T1ZRWUFKbDRydw?oc=5","date":"2021-12-14","type":"deal","source":"BioSpace","summary":"CSL Tenders Offer to Buy Vifor Pharma for $11.7 Billion - BioSpace","headline":"CSL Tenders Offer to Buy Vifor Pharma for $11.7 Billion","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_1":1},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}